Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,779 | 72,187 | 68,717 | 47,024 | 9,180 |
| Marketable Securities | 14,525 | 39,974 | N/A | N/A | 0 |
| Receivables | 1,254 | 1,989 | 157 | 1,085 | 1,210 |
| Other current assets | 128 | 538 | 385 | 2,805 | 1,400 |
| TOTAL | $183,882 | $116,418 | $70,343 | $51,244 | $11,790 |
| Non-Current Assets | |||||
| PPE Net | 3,183 | 1,760 | 1,373 | 1,352 | 2,190 |
| Investments And Advances | 10,070 | 0 | 0 | 0 | 0 |
| Intangibles | 515,156 | 0 | 0 | 0 | 0 |
| TOTAL | $528,409 | $1,760 | $1,373 | $1,352 | $2,190 |
| Total Assets | $712,291 | $118,178 | $71,716 | $52,595 | $13,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,827 | 9,328 | 3,680 | 3,796 | 1,300 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,520 |
| Other current liabilities | 883 | 5,099 | 5,379 | 4,015 | 3,240 |
| TOTAL | $10,578 | $20,206 | $12,522 | $10,954 | $6,980 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 868 | 5,779 | 3,463 | 3,144 | N/A |
| Other Non-Current Liabilities | 7,497 | 0 | 0 | 0 | 0 |
| TOTAL | $154,034 | $9,937 | $N/A | $722 | $1,710 |
| Total Liabilities | $164,612 | $30,143 | $12,522 | $11,676 | $8,670 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,626 | 46,568 | 21,946 | 14,305 | N/A |
| Common Shares | 834,240 | 290,004 | 216,702 | 181,786 | 236,300 |
| Retained earnings | -266,985 | -205,864 | -167,027 | -152,962 | -258,840 |
| Other shareholders' equity | -49,782 | -22,313 | -15,824 | -12,691 | -3,170 |
| TOTAL | $547,679 | $88,035 | $59,194 | $40,919 | $5,310 |
| Total Liabilities And Equity | $712,291 | $118,178 | $71,716 | $52,595 | $13,980 |